Comparison of Social Support Levels of Gynecological Oncology Patients in the First and Fourth Cycles of Chemotherapy

Cemile Alaca

Makale detayları

Comparison of Social Support Levels of Gynecological Oncology Patients in the First and Fourth Cycles of Chemotherapy

Yazarlar:

Cemile Alaca

Yayıncı:

Ankara University

Ana Başlıklar:

Gynecologic Oncology Surgery

Dergi:

Ankara Üniversitesi Tıp Fakültesi Mecmuası Vol.77 Issue 2, pp.156-163

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001349759

pISSN:

0365-8104

Anahtar kelimeler:

Özet:

 Objectives: The aim of this study was to compare the social support levels of gynecological oncology patients regarding the first and fourth cycles of chemotherapy. Materials and Methods: This descriptive study was planned to determine the social support levels of 50 women admitted to the gynecological oncology outpatient clinic and service in Ankara University Health Practice and Research Hospitals, Clinic of Obstetrics and Gyneacology during the first and fourth cycles of chemotherapy. After the informed consent form was read and signed by the women who met the research criteria and agreed to participate in the study, the data were collected face-to-face with the Descriptive Characteristics Form and Cancer Patient Social Support Scale. Results: The age of the 50 participants was 59.2010.18 years, the number of pregnancies was 3.181.83, the number of births was 2.421.48, and the age at menopause was 46.867.91. The initial score was 130.818.23 and the final score was 130.4617.94. When the score change was analysed, it was found to be -0.3418.52. When compared according to the 1st cycle and 4th cycle chemotherapy treatments of the participants in the study, an increase of 10 was observed in 26 of the patients in the scale scores. It was observed that there was a significant difference with those who had a good degree of knowledge about the disease, and there was a significant difference with the question of with whom the patient lived at home. No significant difference was found in other evaluation criteria. When the Pearson correlation analyses of the change in the scale score and the 10 increase in the score of the participants according to the 1st cycle and 4th cycle chemotherapy treatments were examined, it was determined that the degree of knowledge about the disease showed a moderate negative correlation. In the score change, it was found that there was a moderate negative correlation with with whom she lived at home. Conclusion: It is recommended to determine the social support levels and needs of women diagnosed with gynecological cancer in chemotherapy treatment processes and to cooperate with the patients family and environment in this direction.

 Objectives: The aim of this study was to compare the social support levels of gynecological oncology patients regarding the first and fourth cycles of chemotherapy. Materials and Methods: This descriptive study was planned to determine the social support levels of 50 women admitted to the gynecological oncology outpatient clinic and service in Ankara University Health Practice and Research Hospitals, Clinic of Obstetrics and Gyneacology during the first and fourth cycles of chemotherapy. After the informed consent form was read and signed by the women who met the research criteria and agreed to participate in the study, the data were collected face-to-face with the Descriptive Characteristics Form and Cancer Patient Social Support Scale. Results: The age of the 50 participants was 59.2010.18 years, the number of pregnancies was 3.181.83, the number of births was 2.421.48, and the age at menopause was 46.867.91. The initial score was 130.818.23 and the final score was 130.4617.94. When the score change was analysed, it was found to be -0.3418.52. When compared according to the 1st cycle and 4th cycle chemotherapy treatments of the participants in the study, an increase of 10 was observed in 26 of the patients in the scale scores. It was observed that there was a significant difference with those who had a good degree of knowledge about the disease, and there was a significant difference with the question of with whom the patient lived at home. No significant difference was found in other evaluation criteria. When the Pearson correlation analyses of the change in the scale score and the 10 increase in the score of the participants according to the 1st cycle and 4th cycle chemotherapy treatments were examined, it was determined that the degree of knowledge about the disease showed a moderate negative correlation. In the score change, it was found that there was a moderate negative correlation with with whom she lived at home. Conclusion: It is recommended to determine the social support levels and needs of women diagnosed with gynecological cancer in chemotherapy treatment processes and to cooperate with the patients family and environment in this direction.

 Objectives: The aim of this study was to compare the social support levels of gynecological oncology patients regarding the first and fourth cycles of chemotherapy. Materials and Methods: This descriptive study was planned to determine the social support levels of 50 women admitted to the gynecological oncology outpatient clinic and service in Ankara University Health Practice and Research Hospitals, Clinic of Obstetrics and Gyneacology during the first and fourth cycles of chemotherapy. After the informed consent form was read and signed by the women who met the research criteria and agreed to participate in the study, the data were collected face-to-face with the Descriptive Characteristics Form and Cancer Patient Social Support Scale. Results: The age of the 50 participants was 59.2010.18 years, the number of pregnancies was 3.181.83, the number of births was 2.421.48, and the age at menopause was 46.867.91. The initial score was 130.818.23 and the final score was 130.4617.94. When the score change was analysed, it was found to be -0.3418.52. When compared according to the 1st cycle and 4th cycle chemotherapy treatments of the participants in the study, an increase of 10 was observed in 26 of the patients in the scale scores. It was observed that there was a significant difference with those who had a good degree of knowledge about the disease, and there was a significant difference with the question of with whom the patient lived at home. No significant difference was found in other evaluation criteria. When the Pearson correlation analyses of the change in the scale score and the 10 increase in the score of the participants according to the 1st cycle and 4th cycle chemotherapy treatments were examined, it was determined that the degree of knowledge about the disease showed a moderate negative correlation. In the score change, it was found that there was a moderate negative correlation with with whom she lived at home. Conclusion: It is recommended to determine the social support levels and needs of women diagnosed with gynecological cancer in chemotherapy treatment processes and to cooperate with the patients family and environment in this direction.

 Amaç: Bu çalışma ile jinekolojik onkoloji hastalarının, kemoterapinin birinci ve dördüncü kür tedavilerine ilişkin sosyal destek düzeylerini karşılaştırmak amaçlanmıştır. Gereç ve Yöntem: Bu araştırma, Ankara Üniversitesi Sağlık Uygulama ve Araştırma Hastaneleri, Kadın Hastalıkları ve Doğum Kliniğinde Jinekolojik Onkoloji Polikliniğine ve servisine başvuran 50 kadının kemoterapinin birinci ve dördüncü kürlerindeki sosyal destek düzeylerini belirlemek amacı ile tanımlayıcı tipte planlanmıştır. Araştırma kriterlerine uygun ve çalışmaya katılmayı kabul eden kadınlara aydınlatılmış onam formu okutulup, imzalatıldıktan sonra Tanıtıcı Özellikler Formu ve Kanser Hastası Sosyal Destek Ölçeği ile veriler yüz yüze olarak toplanmıştır. Bulgular: Ölçek puanlaması hesaplanan 50 katılımcının yaş 59,2010,18, gebelik sayısı 3,181,83, doğum sayısı 2,421,48, menopoz yaşı 46,867,91 olarak değerlendirilmiştir. Ölçek sonucunda ilk skor 130,818,23 ve son skor 130,4617,94 belirlenmiştir. Skor değişimi incelendiğinde -0,3418,52 olarak bulunmuştur. Araştırmaya katılanların 1. kür ve 4. kür kemoterapi tedavilerine göre karşılaştırıldığında ölçek puanlarında hastaların 26sında en az 10 olarak skorda artış tanımladık. Hastalığa ilişkin bilgi derecesi iyi olanlar ile anlamlı bir fark olduğu, hastanın evde kiminle yaşadığı sorusu ile de anlamlıya yakın bir fark olduğu görülmüştür. Diğer değerlendirme kriterlerinde ise anlamlı bir fark bulunamamıştır. Araştırmaya katılanların 1. kür ve 4. kür kemoterapi tedavilerine göre karşılaştırıldığında, ölçek skorunda değişim ve skorda artış görülme durumlarının Pearson korelasyon analizleri incelendiğinde, hastalığa ilişkin bilgi derecesi orta derecede negatif korelasyon gösterdiği belirlenmiştir. Skor değişiminde ise evde kiminle yaşadığı ile orta derecede negatif korelasyon gösterdiği bulunmuştur. Sonuç: Jinekolojik kanser tanılı kadınların kemoterapi tedavi süreçlerindeki sosyal destek düzeylerinin, gereksinimlerinin belirlenmesi ve bu doğrultuda hasta ailesi ve çevresi ile işbirliği yapılması önerilmektedir.

Makale detayları

Comparison of Social Support Levels of Gynecological Oncology Patients in the First and Fourth Cycles of Chemotherapy

Yazarlar:

Cemile Alaca

Yayıncı:

Ankara University

Ana Başlıklar:

Gynecologic Oncology Surgery

Dergi:

Ankara Üniversitesi Tıp Fakültesi Mecmuası Vol.77 Issue 2, pp.156-163

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001349759

pISSN:

0365-8104

Gynecological cancer

social support

chemotherapyJinekolojik kanser

sosyal destek

kemoterapi

Sayı

Makale detayları

Comparison of Social Support Levels of Gynecological Oncology Patients in the First and Fourth Cycles of Chemotherapy

Yazarlar: Cemile Alaca

Yayıncı: Ankara University

Ana Başlıklar: Gynecologic Oncology Surgery

Dergi: Ankara Üniversitesi Tıp Fakültesi Mecmuası Vol.77 Issue 2, pp.156-163

Belge Tipi: Makale

Yayın Tarihi: 12/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001349759

pISSN: 0365-8104

Gynecological cancer

social support

chemotherapyJinekolojik kanser

sosyal destek

kemoterapi

Sayı

Yazarlar:

Cemile Alaca

Yayıncı:

Ankara University

Ana Başlıklar:

Gynecologic Oncology Surgery

Dergi:

Ankara Üniversitesi Tıp Fakültesi Mecmuası Vol.77 Issue 2, pp.156-163

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001349759

pISSN:

0365-8104